Open AccessAssociation of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding
Author(s) -
Wayne A. Ray,
Cecilia P. Chung,
Katherine T. Murray,
Walter Smalley,
James R. Daugherty,
William D. Dupont,
C. Michael Stein
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2018.17242
Subject(s) - medicine , rivaroxaban , apixaban , dabigatran , incidence (geometry) , warfarin , cohort , gastrointestinal bleeding , cohort study , anticoagulant , proton pump inhibitor , retrospective cohort study , atrial fibrillation , surgery , gastroenterology , physics , optics
Anticoagulant choice and proton pump inhibitor (PPI) cotherapy could affect the risk of upper gastrointestinal tract bleeding, a frequent and potentially serious complication of oral anticoagulant treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom